Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1984 Apr;199(4):375–382. doi: 10.1097/00000658-198404000-00001

The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials.

N Wolmark, B Fisher, H S Wieand, R S Henry, H Lerner, S Legault-Poisson, P J Deckers, N Dimitrov, P H Gordon, P Jochimsen, et al.
PMCID: PMC1353353  PMID: 6370155

Abstract

This analysis explores the prognostic significance of preoperative carcinoembryonic antigen (CEA) levels in patients with colorectal cancer. The data were derived from 945 patients entered into two randomized prospective clinical trials of the National Surgical Adjuvant Breast and Bowel Project. A strong correlation was evident between preoperative CEA level and Dukes class. The mean CEA progressively increased with each Dukes category and the mean value for each of the four classes was significantly different. This relationship was prevalent whether the data were analyzed for all colorectal lesions regardless of location or specifically for right-sided colon tumors. The prognostic function of preoperative CEA level was independent of the number of positive histologic nodes. Preoperative CEA level correlated with the degree of lumen encirclement by tumor. Tumors that did not encircle more than one half the lumen were associated with significantly lower preoperative CEA levels than those that did. The presence or absence of lumen obstruction was unrelated to the preoperative CEA level. The relative risk of developing a treatment failure was associated with preoperative CEA, in both Dukes B and C patients, demonstrating that the prognostic significance of preoperative CEA was independent of Dukes class.

Full text

PDF
375

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Costanza M. E., Das S., Nathanson L., Rule A., Schwartz R. S. Proceedings: Carcinoembryonic antigen. Report of a screening study. Cancer. 1974 Feb;33(2):583–590. doi: 10.1002/1097-0142(197402)33:2<583::aid-cncr2820330238>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  2. Gold P., Freedman S. O. Specific carcinoembryonic antigens of the human digestive system. J Exp Med. 1965 Sep 1;122(3):467–481. doi: 10.1084/jem.122.3.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Goslin R., Steele G., Jr, Macintyre J., Mayer R., Sugarbaker P., Cleghorn K., Wilson R., Zamcheck N. The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers. Ann Surg. 1980 Dec;192(6):747–751. doi: 10.1097/00000658-198012000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hansen H. J., Snyder J. J., Miller E., Vandevoorde J. P., Miller O. N., Hines L. R., Burns J. J. Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. Hum Pathol. 1974 Mar;5(2):139–147. doi: 10.1016/s0046-8177(74)80061-4. [DOI] [PubMed] [Google Scholar]
  5. Herrera M. A., Chu T. M., Holyoke E. D. Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma. Ann Surg. 1976 Jan;183(1):5–9. doi: 10.1097/00000658-197601000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Holyoke D., Reynoso G., Chu T. M. Carcinoembryonic antigen (CEA) in patients with carcinoma of the digestive tract. Ann Surg. 1972 Oct;176(4):559–564. doi: 10.1097/00000658-197217640-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Khoo S. K., Mackay I. R. Carcinoembryonic antigen in serum in diseases of the liver and pancreas. J Clin Pathol. 1973 Jul;26(7):470–475. doi: 10.1136/jcp.26.7.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lo Gerfo P., Herter F. P. Carcinoembryonic antigen and prognosis in patients with colon cancer. Ann Surg. 1975 Jan;181(1):81–84. doi: 10.1097/00000658-197501000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lo Gerfo P., Krupey J., Hansen H. J. Demonstration of an antigen common to several varieties of neoplasia. N Engl J Med. 1971 Jul 15;285(3):138–141. doi: 10.1056/NEJM197107152850302. [DOI] [PubMed] [Google Scholar]
  10. Lurie B. B., Loewenstein M. S., Zamcheck N. Elevated carcinoembryonic antigen levels and biliary tract obstruction. JAMA. 1975 Jul 28;233(4):326–330. [PubMed] [Google Scholar]
  11. Lynch H. L., Guirgis H. Carcinoembryonic antigen in families. JAMA. 1973 May 14;224(7):1042–1042. doi: 10.1001/jama.224.7.1042. [DOI] [PubMed] [Google Scholar]
  12. Mach J. P., Jaeger P., Bertholet M. M., Ruegsegger C. H., Loosli R. M., Pettavel J. Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (C.E.A.). Lancet. 1974 Sep 7;2(7880):535–540. doi: 10.1016/s0140-6736(74)91872-8. [DOI] [PubMed] [Google Scholar]
  13. Reynoso G., Chu T. M., Holyoke D., Cohen E., Nemoto T., Wang J. J., Chuang J., Guinan P., Murphy G. P. Carcinoembryonic antigen in patients with different cancers. JAMA. 1972 Apr 17;220(3):361–365. [PubMed] [Google Scholar]
  14. Steele G., Jr, Ellenberg S., Ramming K., O'Connell M., Moertel C., Lessner H., Bruckner H., Horton J., Schein P., Zamcheck N. CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols. Ann Surg. 1982 Aug;196(2):162–169. doi: 10.1097/00000658-198208000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sugarbaker P. H. Carcinoma of the colon--prognosis and operative choice. Curr Probl Surg. 1981 Dec;18(12):753–802. doi: 10.1016/s0011-3840(81)80010-x. [DOI] [PubMed] [Google Scholar]
  16. Thomson D. M., Krupey J., Freedman S. O., Gold P. The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc Natl Acad Sci U S A. 1969 Sep;64(1):161–167. doi: 10.1073/pnas.64.1.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Turnbull R. B., Jr, Kyle K., Watson F. R., Spratt J. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg. 1967 Sep;166(3):420–427. doi: 10.1097/00000658-196709000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wanebo H. J., Rao B., Pinsky C. M., Hoffman R. G., Stearns M., Schwartz M. K., Oettgen H. F. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med. 1978 Aug 31;299(9):448–451. doi: 10.1056/NEJM197808312990904. [DOI] [PubMed] [Google Scholar]
  19. Wolmark N., Cruz I., Redmond C. K., Fisher B., Fisher E. R. Tumor size and regional lymph node metastasis in colorectal cancer. A preliminary analysis from the NSABP clinical trials. Cancer. 1983 Apr 1;51(7):1315–1322. doi: 10.1002/1097-0142(19830401)51:7<1315::aid-cncr2820510723>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  20. Wolmark N., Wieand H. S., Rockette H. E., Fisher B., Glass A., Lawrence W., Lerner H., Cruz A. B., Volk H., Shibata H. The prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer. Findings from the NSABP clinical trials. Ann Surg. 1983 Dec;198(6):743–752. doi: 10.1097/00000658-198312000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Zamcheck N. The present status of DEA in diagnosis, prognosis, and evaluation of therapy. Cancer. 1975 Dec;36(6 Suppl):2460–2468. doi: 10.1002/1097-0142(197512)36:6<2460::aid-cncr2820360631>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  22. Zupchik H. Z., Zamcheck N., Saravis C. A. Editorial: Immunochemical studies of carcinoembryonic antigens: methodologic considerations and some clinical implications. J Natl Cancer Inst. 1973 Dec;51(6):1741–1749. doi: 10.1093/jnci/51.6.1741. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES